Cargando…
Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard(®)
We report the case of a 19-year-old woman who received a complete vaccine program by Gardasil. After one year, Greiner HPV test revealed HPV51 positivity. This case report highlights the limits of the vaccine, and the need to have a clinical follow up of patients despite the vaccination program.
Autores principales: | Halfon, Philippe, Ravet, Sophie, Khiri, Hacène, Penaranda, Guillaume, Lefoll, Carole |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046010/ https://www.ncbi.nlm.nih.gov/pubmed/21769258 http://dx.doi.org/10.4137/CCRep.S6177 |
Ejemplares similares
-
HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test
por: Halfon, Philippe, et al.
Publicado: (2013) -
Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assays
por: Halfon, Philippe, et al.
Publicado: (2013) -
A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil(®))
por: Govan, Vandana A
Publicado: (2008) -
A novel trivalent HPV 16/18/58 vaccine with anti-HPV 16 and 18 neutralizing antibody responses comparable to those induced by the Gardasil quadrivalent vaccine in rhesus macaque model
por: Yin, Fei, et al.
Publicado: (2017) -
Quantification of HPV16 E6/E7 mRNA Spliced Isoforms Viral Load as a Novel Diagnostic Tool for Improving Cervical Cancer Screening
por: Camus, Claire, et al.
Publicado: (2018)